VF
LAB icon

Virtu Financial’s Standard BioTools LAB Stock Holding History

Virtu Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80K Buy
+97,202
New +$91.8K ﹤0.01% 1148
2026
Q1 		– Sell
-62,129
Closed -$80K – 2002
2025
Q4 		$80K Buy
62,129
+3,433
+6% +$4.61K ﹤0.01% 1234
2025
Q3 		$76K Buy
+58,696
New +$76.9K ﹤0.01% 1078
2024
Q3 		– Sell
-24,201
Closed -$43K – 1643
2024
Q2 		$43K Buy
+24,201
New +$59.2K ﹤0.01% 924
2023
Q1 		– Sell
-16,167
Closed -$19K – 1813
2022
Q4 		$19K Buy
+16,167
New +$19.9K ﹤0.01% 1279
2022
Q2 		– Sell
-14,270
Closed -$51K – 1833
2022
Q1 		$51K Buy
+14,270
New +$49.3K ﹤0.01% 1127
2018
Q3 		– Sell
-12,784
Closed -$76K – 1904
2018
Q2 		$76K Buy
+12,784
New +$72.9K ﹤0.01% 1700
2018
Q1 		– Sell
-13,523
Closed -$80K – 2293
2017
Q4 		$80K Buy
+13,523
New +$74K ﹤0.01% 1974

Other funds holding LAB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's LAB Position: Q2 2026 in Review

Virtu Financial opened a new position in Standard BioTools (LAB) in Q2 2026: 97,202 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LAB as recently as Q4 2025.

Virtu Financial first reported a position in LAB in Q4 2017 and has held it in 8 quarters since. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Virtu Financial held 97,202 shares of Standard BioTools worth $80K as of Q2 2026.
  • Standard BioTools was a new Virtu Financial position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1148 holding.
  • Virtu Financial first reported a position in Standard BioTools in Q4 2017 and has held it in 8 quarters since.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.